At a glance
ClinicalIndex Comparison RecordN/ACompleted· 404 enrolled
Drug / intervention
Labetalol Hydrochloride +10 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised Trial to Establish the Effects of Early Intensive Blood Pressure Lowering on Death and Disability in Patients With Stroke Due to Acute Intracerebral Haemorrhage
In Brief
A clinical study evaluating Labetalol Hydrochloride, Metoprolol tartrate, and 9 other interventions for CVA (Cerebrovascular Accident) and 2 related conditions. Completed, enrolled 404 participants across 20 sites in 3 countries.
Detailed Summary
The purpose of the study is to determine whether lowering high blood pressure levels after the start of a stroke caused by bleeding in the brain (intracerebral haemorrhage) will reduce the chances of a person dying or surviving with a long term disability. The study will be undertaken in two phases: a vanguard phase in 400 patients, to plan for a main phase in 2000 patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia, China, New Zealand
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 2005
Enrollment StartNov 2005
Primary CompletionSep 2007
TodayJul 2026
First PostedSep 26, 2005
Enrollment StartNov 1, 2005
Primary CompletionSep 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 20.8 years ago
Interventions
Labetalol Hydrochloridedrug
Metoprolol tartratedrug
Hydralazine Hydrochloridedrug
Glycerol Trinitratedrug
Phentolamine mesylatedrug
Nicardipinedrug
Urapidildrug
Esmololdrug
Clonidinedrug
Enalaprilatdrug
Nitroprussidedrug